BioCentury
ARTICLE | Company News

Taiho seeking Japanese approval for TAS-102

February 28, 2013 2:08 AM UTC

Taiho Pharmaceutical Co. Ltd. submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for TAS-102 to treat unresectable, advanced, recurrent colorectal cancer. The p...